China
In this section you will find Country China market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
China Healthcare Sector Analysis
$800.00Published by RNCOS on Apr 1st, 2011Chinese healthcare industry is entering into a new phase with the advanced development of infrastructure. The industry enjoys many benefits including, large population, rising aging population, and continuously growing prevalence... Learn More -
The Top 10 CMOs in China
$3,835.00Published by Business Insights on Jan 11th, 2011This report discusses market dynamics, drivers, resistors and future outlook of CMO industry in China. It also includes manufacturing capabilities, growth strategies, SWOT analysis of the top 10 CMOs. Other... Learn More -
OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
$995.00Published by Datamonitor on Nov 1st, 2010Datamonitor’s OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) OTC Pharmaceuticals industry... Learn More -
Chinese Pharmaceutical Market 2010-2025
$2,461.00Published by Visiongain on Oct 14th, 2010what prospects can you find there? Our new report will show you how the Chinese pharma market will develop from 2010. You can identify where the greatest opportunities will lie... Learn More -
Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
$7,600.00Published by Datamonitor on Aug 19th, 2010Expanding healthcare coverage in emerging Asia-Pacific markets, rapid economic growth and burgeoning middle classes are attracting foreign M&A as companies attempt to offset future losses from the looming... Learn More -
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
$995.00Published by Datamonitor on Mar 31st, 2010Datamonitor’s Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report... Learn More -
Pharmaceuticals: China Industry Guide
$995.00Published by Datamonitor on Feb 17th, 2010Datamonitor’s Pharmaceuticals: China Industry Guide is an essential resource for top-level data and analysis covering the China Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual... Learn More -
Chinese Pharmaceutical Market Outlook 2009-2024
$2,461.00Published by Visiongain on Aug 27th, 2009This report - Chinese Pharmaceutical Market Outlook 2009-2024 - analyses prospects for the pharma market and industry sector in China. Learn More -
Emerging Clinical Trial Locations - China: Market dynamics and the changing healthcare and regulatory environment
$3,835.00Published by Business Insights on Jun 17th, 2009This report identifies market dynamics and key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in China. Learn More -
Personal Hygiene/ Personal Care: China Industry Guide
$1,110.00Published by Datamonitor on Apr 8th, 2009This report is an essential resource for top-level data and analysis covering the China Personal Hygiene/ Personal Care industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. Learn More -
Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
$3,835.00Published by Business Insights on Dec 1st, 2008This report explores the expanding pharma outsourcing market in China to discover how large pharma, small-sized pharma and biotech can most effectively utilize the country’s service offerings and capabilities. Learn More -
Lipitor Market analysis and forecasts Report, 2007-2012, 2017 & 2023
$2,461.00Published by Visiongain on Apr 30th, 2008In 2006, Pfizer’s Lipitor (atorvastatin) generated global revenues of $13.6bn, making it the best selling drug in pharmaceutical history. The blockbuster medicine has single-handedly driven the overall revenue margins of the cardiovascular segment, as this area continues to dominate the pharmaceutical market. Learn More -
Chinese Pharmaceutical Outlook 2008-2023
$2,461.00Published by Visiongain on Apr 16th, 2008This brand new report examines the prospects for the growth of pharmaceutical revenues in China. Learn More -
Pharmaceuticals in China
$250.00Published by Datamonitor on Dec 17th, 2007Pharmaceuticals in China industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. Learn More -
Drug Development Opportunities in China: Regulation, key players and initiatives for domestic and international markets
$2,875.00Published by Business Insights on Sep 1st, 2007This report will examine the methods of expansion adopted by China’s pharma companies, biotech developers and CRO’s to increase the scale of their drug development operations, in addition to identifying their therapeutic interests and development lifecycle focus. Learn More
China
In this section you will find Country China market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
China Healthcare Sector Analysis
$800.00Published by RNCOS on Apr 1st, 2011Chinese healthcare industry is entering into a new phase with the advanced development of infrastructure. The industry enjoys many benefits including, large population, rising aging population, and continuously growing prevalence... Learn More -
The Top 10 CMOs in China
$3,835.00Published by Business Insights on Jan 11th, 2011This report discusses market dynamics, drivers, resistors and future outlook of CMO industry in China. It also includes manufacturing capabilities, growth strategies, SWOT analysis of the top 10 CMOs. Other... Learn More -
OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
$995.00Published by Datamonitor on Nov 1st, 2010Datamonitor’s OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) OTC Pharmaceuticals industry... Learn More -
Chinese Pharmaceutical Market 2010-2025
$2,461.00Published by Visiongain on Oct 14th, 2010what prospects can you find there? Our new report will show you how the Chinese pharma market will develop from 2010. You can identify where the greatest opportunities will lie... Learn More -
Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
$7,600.00Published by Datamonitor on Aug 19th, 2010Expanding healthcare coverage in emerging Asia-Pacific markets, rapid economic growth and burgeoning middle classes are attracting foreign M&A as companies attempt to offset future losses from the looming... Learn More -
Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
$995.00Published by Datamonitor on Mar 31st, 2010Datamonitor’s Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report... Learn More -
Pharmaceuticals: China Industry Guide
$995.00Published by Datamonitor on Feb 17th, 2010Datamonitor’s Pharmaceuticals: China Industry Guide is an essential resource for top-level data and analysis covering the China Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual... Learn More -
Chinese Pharmaceutical Market Outlook 2009-2024
$2,461.00Published by Visiongain on Aug 27th, 2009This report - Chinese Pharmaceutical Market Outlook 2009-2024 - analyses prospects for the pharma market and industry sector in China. Learn More -
Emerging Clinical Trial Locations - China: Market dynamics and the changing healthcare and regulatory environment
$3,835.00Published by Business Insights on Jun 17th, 2009This report identifies market dynamics and key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in China. Learn More -
Personal Hygiene/ Personal Care: China Industry Guide
$1,110.00Published by Datamonitor on Apr 8th, 2009This report is an essential resource for top-level data and analysis covering the China Personal Hygiene/ Personal Care industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. Learn More -
Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
$3,835.00Published by Business Insights on Dec 1st, 2008This report explores the expanding pharma outsourcing market in China to discover how large pharma, small-sized pharma and biotech can most effectively utilize the country’s service offerings and capabilities. Learn More -
Lipitor Market analysis and forecasts Report, 2007-2012, 2017 & 2023
$2,461.00Published by Visiongain on Apr 30th, 2008In 2006, Pfizer’s Lipitor (atorvastatin) generated global revenues of $13.6bn, making it the best selling drug in pharmaceutical history. The blockbuster medicine has single-handedly driven the overall revenue margins of the cardiovascular segment, as this area continues to dominate the pharmaceutical market. Learn More -
Chinese Pharmaceutical Outlook 2008-2023
$2,461.00Published by Visiongain on Apr 16th, 2008This brand new report examines the prospects for the growth of pharmaceutical revenues in China. Learn More -
Pharmaceuticals in China
$250.00Published by Datamonitor on Dec 17th, 2007Pharmaceuticals in China industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. Learn More -
Drug Development Opportunities in China: Regulation, key players and initiatives for domestic and international markets
$2,875.00Published by Business Insights on Sep 1st, 2007This report will examine the methods of expansion adopted by China’s pharma companies, biotech developers and CRO’s to increase the scale of their drug development operations, in addition to identifying their therapeutic interests and development lifecycle focus. Learn More